Exelixis, Inc. (EXEL)
69.84
-0.86
(-1.22%)
USD |
NASDAQ |
Nov 12, 16:00
69.81
-0.03
(-0.04%)
After-Hours: 20:00
Exelixis Price : 69.84 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 70.70 | 70.94 | 69.67 | 69.84 | 1.632M |
| Nov 11, 2026 | 70.47 | 70.96 | 69.66 | 70.70 | 2.230M |
| Nov 10, 2026 | 71.56 | 72.14 | 69.74 | 70.58 | 5.584M |
| Nov 09, 2026 | 70.21 | 72.15 | 69.39 | 71.74 | 4.826M |
| Nov 06, 2026 | 68.35 | 70.32 | 68.01 | 69.57 | 2.004M |
| Nov 05, 2026 | 73.03 | 73.69 | 68.46 | 68.71 | 4.376M |
| Nov 04, 2026 | 73.18 | 73.41 | 71.31 | 72.75 | 3.014M |
| Nov 03, 2026 | 70.11 | 73.44 | 70.11 | 72.31 | 3.849M |
| Nov 02, 2026 | 69.52 | 72.01 | 69.15 | 70.13 | 5.591M |
| Oct 30, 2026 | 68.28 | 72.10 | 67.05 | 69.39 | 5.072M |
| Oct 29, 2026 | 66.93 | 67.52 | 65.06 | 66.20 | 2.839M |
| Oct 28, 2026 | 64.90 | 66.38 | 64.75 | 66.28 | 1.641M |
| Oct 27, 2026 | 64.70 | 65.48 | 64.38 | 65.35 | 1.432M |
| Oct 26, 2026 | 64.85 | 65.58 | 64.57 | 65.11 | 1.675M |
| Oct 23, 2026 | 65.15 | 65.20 | 63.91 | 64.53 | 2.066M |
| Oct 22, 2026 | 64.74 | 65.50 | 64.33 | 65.31 | 1.710M |
| Oct 21, 2026 | 64.12 | 64.78 | 64.11 | 64.58 | 1.494M |
| Oct 20, 2026 | 63.01 | 64.42 | 62.84 | 64.39 | 2.137M |
| Oct 19, 2026 | 61.84 | 62.81 | 61.67 | 62.68 | 1.934M |
| Oct 16, 2026 | 62.98 | 63.39 | 61.74 | 62.23 | 2.638M |
| Oct 15, 2026 | 61.69 | 63.31 | 61.28 | 62.83 | 2.774M |
| Oct 14, 2026 | 59.92 | 61.18 | 59.56 | 60.99 | 2.753M |
| Oct 13, 2026 | 60.00 | 60.00 | 58.59 | 59.51 | 2.625M |
| Oct 12, 2026 | 60.48 | 61.66 | 59.80 | 59.82 | 3.129M |
| Oct 09, 2026 | 59.00 | 60.83 | 59.00 | 59.86 | 2.666M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 56.70 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Cytokinetics, Inc. | 56.16 |
| Gilead Sciences, Inc. | 167.95 |
| Ionis Pharmaceuticals, Inc. | 27.31 |
Price Related Metrics
| PE Ratio | 20.90 |
| PS Ratio | 7.406 |
| PEG Ratio | 0.5138 |
| Price to Book Value | 9.318 |
| Price to Free Cash Flow | 15.93 |
| Earnings Yield | 4.78% |
| Market Cap | 17.09B |
| PEGY Ratio | 0.5138 |
| Operating PE Ratio | 18.42 |
| Normalized PE Ratio | 20.89 |